Advertisement

Is QRS Duration a Reliable Parameter in Discriminating between Supraventricular and Ventricular Arrhythmias?

  • M. Fromer

Abstract

Automatic implantable cardioverter defibrillators (ICDs) are designed to detect and terminate ventricular tachyarrhythmias. Ideally, they do so with a high specificity and sensitivity. Actual ICD technology with detection based mainly on rate provides high sensitivity but moderate specificity. This means that ICD therapy can be initiated by rapid supraventricular tachyarrhythmias. These inappropriate therapies consist either of antitachycardia pacing, cardioversion or defibrillation. Antitachycardia pacing for a supraventricular tachycardia can induce ventricular tachyarrhythmias; in the worse case, this can ultimately lead to arrhythmic death [1]. It is recognized by many publications that inappropriate therapy imposes serious limitations to ICD therapy due to the discomfort associated as well as to the possible serious proarrhythmic consequences [2–7, 11].

Keywords

Ventricular Tachycardia Implantable Cardioverter Defibrillator Supraventricular Tachycardia Ventricular Tachyarrhythmia Reliable Parameter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Birgersdotter-Green U, Rosenqvist M, Lindemans FW, Rydén L, Radegran K (1992) Hotter documented sudden death in a patient with an implantable defibrillator. PACE 15: 1008–1014PubMedCrossRefGoogle Scholar
  2. 2.
    Böcker D, Block M, Isbruch F, Wietholt D, Hammel D, Scheld HH, Borggrefe M, Breithardt G (1993) Comparison of frequency of aggravation of ventricular tachyarrhythmias after implantation of automatic defibrillators using epicardial versus nonthoracotomy lead systems. Am J Cardiol. 71: 1064–1068PubMedCrossRefGoogle Scholar
  3. 3.
    Wietholt D, Block M, Isbruch F, Bäcker D, Borggrefe M, Shenasa M, Breithardt G (1993) Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator. Am J Cardiol 21: 885–894CrossRefGoogle Scholar
  4. 4.
    Fromer M, Brachmann J, Block M, Siebels J, Hoffman E, Almendral J, Ohm 0, den Dulk K, Coumel P, Camm AJ, Touboul P (1992) Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study incorporating 102 implants. Circulation 86: 363–374PubMedCrossRefGoogle Scholar
  5. 5.
    Fromer M, Schläpfer J, Fischer A, Kappenberger L (1991) Experience with a new implantable Pacer-, Cardioverter-, Defibrillator for the therapy of recurrent sustained ventricular tachyarrhythmias: a step toward a universal tachyarrhythmia control device. PACE 14: 1288–1298PubMedCrossRefGoogle Scholar
  6. 6.
    Grimm W, Flores BF, Marchlinski FE (1992) Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverterdefibrillators. PACE 15: 1667–1673PubMedCrossRefGoogle Scholar
  7. 7.
    Johnson NJ, Marchlinski FE (1991) Arrhythmias induced by device antitachycardia therapy due to diagnostic nonspecificity. J Am Coll Cardiol 18: 1418–1425PubMedCrossRefGoogle Scholar
  8. 8.
    A task force of the working groups on cardiac arrhythmias and cardiac pacing of the European Society of Cardiology (1992) Guidelines for the use of implantable cardioverter defibrillators. Eur Heart J 13: 1304–1310Google Scholar
  9. 9.
    Lehmann MH, Saksena S (1991) Implantable cardioverter defibrillators in cardiovascular practice: report of the policy conference of the North American Society of Pacing and Electrophysiology. PACE 14: 969–979PubMedCrossRefGoogle Scholar
  10. 10.
    Olson WH (1997) Sensing and detection of ventricular tachyarrhythmias by the ICD. In: Allessie MA, Fromer M (eds) Atrial and ventricular fibrillation: mechanisms and device therapy. Futura, Armonk NY pp 399–415Google Scholar
  11. 11.
    Wietholt D, Block M, Isbruch F, Bäcker D, Borggrefe M, Shenasa M, Breithardt G (1993) Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator. Am J Cardiol 21: 885–894CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • M. Fromer
    • 1
  1. 1.Division of CardiologyCHUVLausanneSwitzerland

Personalised recommendations